Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.39 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.39 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | APAF1 | O14727 | 1/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | NSD2 | O96028 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18912766 | 0.94 | EPHX1 (0.43) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL1267612 | 0.92 | EPHX1 (0.48) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL26495326 | 0.90 | EPHX1 (0.52) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL14019308 | 0.90 | EPHX1 (0.52) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL21568865 | 0.90 | EPHX1 (0.52) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL20842884 | 0.87 | EPHX1 (0.44) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL16720827 | 0.86 | EPHX1 (0.48) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL3317331 | 0.85 | CYP1A2 (0.45) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL14381294 | 0.85 | EPHX1 (0.37) | PAOXEPHX1ALDH1A1PRMT3CARM1 | |
| SCHEMBL15569827 | 0.85 | PRMT3 (0.45) | PAOXEPHX1PRMT3CARM1PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 899 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279420-A1 | POLYOL BLENDED LIQUID COMPOSITION FOR PRODUCTION OF HYDROCHLOROFLUOROOLEFIN BLOWN POLYURETHANE FOAM, AND ITS APPLICATION | TOSOH CORPORATION (JP) | 2024-08-22 | — | — | US | claimed |
| WO-2022239734-A1 | POLYOL-BASED MIXED LIQUID COMPOSITION FOR PRODUCING HYDROCHLOROFUROOLEFIN FOAMED POLYURETHANE FOAM, AND USE THEREOF | 東ソー株式会社 | 2022-11-17 | — | — | WO | claimed |
| CN-114437309-A | Aqueous dispersion of high-toughness polyurethane or polyurethane urea, preparation method and application thereof | 上海名流卫生用品股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-111019079-B | Aqueous dispersion of polyurethane or polyurethane urea and preparation method and application thereof | 万华化学集团股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| EP-3119829-B1 | CONTROLLED CROSSLINKING OF LATEX POLYMERS WITH POLYFUNCTIONAL AMINES | ENNIS PAINT INC (US) | 2020-08-19 | — | — | EP | claimed |
| US-10717800-B2 | Controlled crosslinking of latex polymers with polyfunctional amines | ENNIS PAINT, INC. (US) | 2020-07-21 | — | — | US | claimed |
| US-20200109117-A1 | Modified Therapeutic Agent Analogs of Mefenamic Acid | Q BIOMED INC. | 2020-04-09 | — | — | US | claimed |
| US-10377878-B2 | Controlled crosslinking of latex polymers with polyfunctional amines | ENNIS PAINT, INC. (US) | 2019-08-13 | — | — | US | claimed |
| US-10233279-B2 | Poly(THF)-based polyurethane dispersions | Covestro-Deutschland AG (DE) | 2019-03-19 | — | — | US | claimed |
| EP-3247756-A1 | POLYFUNCTIONAL AMINES WITH HYDROPHOBIC MODIFICATION FOR CONTROLLED CROSSLINKING OF LATEX POLYMERS | Ennis Paint Inc. (US) | 2017-11-29 | — | — | EP | claimed |
| EP-1163212-A1 | AMIDE DERIVATIVES | AstraZeneca AB (SE) | 2001-12-19 | — | — | EP | claimed |
| EP-1163237-A1 | AMIDE DERIVATIVES | AstraZeneca AB (SE) | 2001-12-19 | — | — | EP | claimed |
| EP-1102743-A1 | AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS | AstraZeneca AB (SE) | 2001-05-30 | — | — | EP | claimed |
| EP-1102750-A1 | AMIDE DERIVATIVES USEFUL AS INHIBITORS OF THE PRODUCTION OF CYTOKINES | AstraZeneca AB (SE) | 2001-05-30 | — | — | EP | claimed |
| EP-1077931-A1 | BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES | AstraZeneca AB (SE) | 2001-02-28 | — | — | EP | claimed |
| WO-2000055120-A1 | AMIDE DERIVATIVES | ASTRAZENECA AB (SE) | 2000-09-21 | — | — | WO | claimed |
| WO-2000055153-A1 | AMIDE DERIVATIVES | ASTRAZENECA AB (SE) | 2000-09-21 | — | — | WO | claimed |
| WO-2000007991-A1 | AMIDE DERIVATIVES USEFUL AS INHIBITORS OF THE PRODUCTION OF CYTOKINES | ASTRAZENECA AB (SE) | 2000-02-17 | — | — | WO | claimed |
| WO-2000007980-A1 | AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS | ASTRAZENECA AB (SE) | 2000-02-17 | — | — | WO | claimed |
| WO-1999059959-A1 | BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES | ASTRAZENECA AB (SE) | 1999-11-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10717800-B2 | Controlled crosslinking of latex polymers with polyfunctional amines | ALG1, LTA, LTN1 | PAOX 1268/4885EPHX1 1282/4885ALDH1A1 1969/4885 |
| US-10377878-B2 | Controlled crosslinking of latex polymers with polyfunctional amines | ALG1, LTA, LTN1 | PAOX 1268/4885EPHX1 1282/4885ALDH1A1 1969/4885 |
| US-20200109117-A1 | Modified Therapeutic Agent Analogs of Mefenamic Acid | FABP7, SLC19A1, FAHD1 | PAOX 655/4885EPHX1 198/4885ALDH1A1 274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.